New study tracks how cystic fibrosis changes with modern drugs
NCT ID NCT04353752
First seen Apr 13, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study followed 58 adults with cystic fibrosis to see how their bodies respond to CFTR modulator treatments. Researchers collected blood, sputum, urine, and quality-of-life surveys before and after starting the drugs. The goal was to track changes in inflammation, lung bacteria, and lung function over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Jewish Health
Denver, Colorado, 80206, United States
Conditions
Explore the condition pages connected to this study.